SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

FDC - Quaterly Results

25 May 2022 Evaluate
The revenue zoomed 8.04% to Rs. 3366.07 millions for the quarter ended March 2022 as compared to Rs. 3115.54 millions during the corresponding quarter last year.Net Profit of the company move down -65.73% to Rs. 143.80  millions from Rs. 419.65 millions  in the same quarter last year.The company reported a degrowth in operating Profit to 288.09 millions from 594.45 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 3366.07 3115.54 8.04 15189.65 13254.49 14.60 15189.65 13254.49 14.60
Other Income 116.01 220.96 -47.50 787.34 971.46 -18.95 787.34 971.46 -18.95
PBIDT 288.09 594.45 -51.54 3255.80 4214.76 -22.75 3255.80 4214.76 -22.75
Interest 6.88 10.47 -34.29 30.48 34.02 -10.41 30.48 34.02 -10.41
PBDT 281.21 583.98 -51.85 3225.32 4180.74 -22.85 3225.32 4180.74 -22.85
Depreciation 91.62 94.80 -3.35 370.81 376.23 -1.44 370.81 376.23 -1.44
PBT 189.59 489.18 -61.24 2854.51 3804.51 -24.97 2854.51 3804.51 -24.97
TAX 45.79 69.53 -34.14 658.15 859.61 -23.44 658.15 859.61 -23.44
Deferred Tax 11.79 -7.47 -257.83 -21.85 14.45 -251.21 -21.85 14.45 -251.21
PAT 143.80 419.65 -65.73 2196.36 2944.90 -25.42 2196.36 2944.90 -25.42
Equity 168.81 168.81 0.00 168.81 168.81 0.00 168.81 168.81 0.00
PBIDTM(%) 8.56 19.08 -55.14 21.43 31.80 -32.59 21.43 31.80 -32.59

FDC Share Price

358.65 2.60 (0.73%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×